Li Li, PhD, discusses how the FDA's approval of the first mRNA flu vaccine could accelerate the development of future mRNA-based therapies while highlighting the scientific challenges that remain.

During the annual Recognition Ceremony, the Morningside Graduate School of Biomedical Sciences celebrated 74 PhD candidates and MD/PhD students who successfully completed their qualifying exam in 2024-2025.

BRIDGE Innovation and Business Development at UMass Chan Medical School has set aside nearly $2 million in funding for six faculty-led research projects that hold promise for translation to clinical application and commercialization.  

UMass Chan researcher Li Li, PhD, writes for The Conversation about how mRNA drug development, which led to the first COVID-19 vaccine, offers significant advantages over traditional drug development.

The UMass Chan community gathered to celebrate 53 PhD candidates and MD/PhD students who transitioned from student to candidate for a doctoral degree during the 2022-2023 academic year.